Cargando…

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome

Hyperandrogenism is a key pathologic characteristic of polycystic ovarian syndrome (PCOS), and exercise can alleviate the accompanying inflammation and decrease the high androgen levels, but the mechanism is still unclear, so the purpose of this study is to explore the pathophysiologic characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Na, Yang, Chenghao, Xie, Huiyu, Liu, Yinghong, Liao, Yuanpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378992/ https://www.ncbi.nlm.nih.gov/pubmed/34422044 http://dx.doi.org/10.1155/2021/5561980

Ejemplares similares

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
por: Soares-Jr, José Maria, et al.
Publicado: (2019)

Polycystic Ovarian Syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters
por: Khan, Ayesha, et al.
Publicado: (2019)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
por: Paixão, Larissa, et al.
Publicado: (2017)

The Distribution of Stroma and Antral Follicles Differs between Insulin-Resistance and Hyperandrogenism-Related Polycystic Ovarian Syndrome
por: Alviggi, Carlo, et al.
Publicado: (2017)

Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
por: Ethirajulu, Aarthi, et al.
Publicado: (2021)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills
por: Fattah, Abdul, et al.
Publicado: (2022)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism
por: Azeemuddin, Mohammed, et al.
Publicado: (2019)

Postmenopausal Hyperandrogenism due to Ovarian Hyperthecosis
por: Metzker, Laryssa Santos, et al.
Publicado: (2023)

Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology
por: Krishnan, Abhaya, et al.
Publicado: (2020)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
por: Guo, Zaixin, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation
por: Sabatini, Mary E, et al.
Publicado: (2011)

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
por: Sørensen, Anja E., et al.
Publicado: (2019)

Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
por: Jin, Congcong, et al.
Publicado: (2021)

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022)

The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Chen, Jianguo, et al.
Publicado: (2021)

Effects of Exercise Combined with Finasteride on Hormone and Ovarian Function in Polycystic Ovary Syndrome Rats
por: Wu, Chuyan, et al.
Publicado: (2019)

Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome
por: Abazar, Elaheh, et al.
Publicado: (2015)

Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome
por: Ho, Vu Ngoc Anh, et al.
Publicado: (2022)

Correction to: The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Chen, Jianguo, et al.
Publicado: (2022)

Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
por: Tessaro, Irene, et al.
Publicado: (2015)

Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation
por: Shao, Yun-yun, et al.
Publicado: (2019)

Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman
por: Fayad, Christine, et al.
Publicado: (2021)

Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism
por: Rajamani, Krishnakumar, et al.
Publicado: (2022)

An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients
por: Liao, Yu, et al.
Publicado: (2017)

Association between ACE gene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls
por: sun, Jing, et al.
Publicado: (2009)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women
por: Ashraf, Sairish, et al.
Publicado: (2021)

An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
por: Gargus, Emma S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_chhv7uhs9h6fgdcutde4u4e0ae